We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Pre-IND

News List

Aptorum Group Announces Positive Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus americanpharmaceuticalreview
May 28, 2021
Aptorum Group Limited, a clinical-stage biopharmaceutical company, announces positive progress in respect of ...
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA americanpharmaceuticalreview
January 15, 2021
Amydis announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for its lead candidate, AMDX-2011P, a small-molecule retinal tracer that targets ...
FDA broadly supports Oragenics’ Pre-IND development programme for SARS-CoV-2 vaccine pharmaceutical-business-review
October 10, 2020
Oragenics, Inc. announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration (“FDA”) that it is in broad agreement with the Company’s planned approach to clinical development of its SARS-CoV-2 vaccine ...